留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

肾功能亢进患者应用万古霉素致急性肾损伤的用药监护

陆灏迪,  唐莲,  方洁,  薛盛敏,  尚尔宁,  薛苏冬

downloadPDF
文章导航 > 药学实践与服务  > 2019 >  37(3): 274-278
陆灏迪, 唐莲, 方洁, 薛盛敏, 尚尔宁, 薛苏冬. 肾功能亢进患者应用万古霉素致急性肾损伤的用药监护[J]. 药学实践与服务, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
引用本文: 陆灏迪, 唐莲, 方洁, 薛盛敏, 尚尔宁, 薛苏冬. 肾功能亢进患者应用万古霉素致急性肾损伤的用药监护[J]. 药学实践与服务, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
shu
LU Haodi, TANG Lian, FANG Jie, XUE Shengmin, SHANG Erning, XUE Sudong. Drug monitoring of acute kidney injury induced by vancomycin in patients with augmented renal clearance[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
Citation: LU Haodi, TANG Lian, FANG Jie, XUE Shengmin, SHANG Erning, XUE Sudong. Drug monitoring of acute kidney injury induced by vancomycin in patients with augmented renal clearance[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
shu

肾功能亢进患者应用万古霉素致急性肾损伤的用药监护

doi: 10.3969/j.issn.1006-0111.2019.03.017
  • 1.

    南京医科大学附属苏州医院药学部, 江苏 苏州 215002

  • 2.

    上海交通大学医学院附属瑞金医院药学部, 上海 200025

基金项目: 江苏省苏州市科技发展计划项目（SYSD2016152）；江苏省药学会医院药学基金项目（A201613）

Drug monitoring of acute kidney injury induced by vancomycin in patients with augmented renal clearance

  • 1.

    Department of Pharmacy, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou 215002, China

  • 2.

    Department of Pharmacy, Ruijin Hospital Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China

  • 摘要: 目的 探讨肾功能亢进患者万古霉素个体化用药中出现急性肾损伤的原因。 方法 对南京医科大学附属苏州医院使用万古霉素且发生急性肾损伤的3个病例进行药学监护，分析使用群体药动学软件预测万古霉素谷浓度准确性差的原因，寻找发生万古霉素急性肾损伤的原因。 结果 在查明患者发生不良反应的原因后，对其进行针对性治疗，均获得较好的控制与转归。 结论 肾功能亢进患者出现万古霉素相关性肾损害主要为联用肾毒性药物、肾脏灌注不足，临床用药中需加强用药监护，提高万古霉素用药安全性。
    Abstract: Objective To investigate the causes of acute kidney injury in patients with augmented renal clearance during individualized application of vancomycin. Methods Three cases of acute kidney injury caused by vancomycin in our hospital were taken pharmaceutical care.The reasons for the inaccuracy of using population pharmacokinetic software to predict the trough concentration of vancomycin were analyzed,and the causes of acute kidney injury caused by vancomycin were found. Results After ascertaining the causes of the adverse reactions of the patients,targeted treatment was carried out,and all of them were well controlled and turned over. Conclusion The main causes of vancomycin-associated renal damage in patients with augmented renal clearance were combined the use of nephrotoxic drugs and renal perfusion insufficiency.It is necessary to strengthen drug monitoring in clinical medication to improve the safety of vancomycin.
  • [1] MAHMOUD S H,SHEN C.Augmentedrenal clearance in critical illness:An important consideration in drug dosing[J].Pharmaceutics,2017,9(3):E36.
    [2] BILBAO-MESEGUER I,RODRÍGUEZ-GASCÓN A,BARRASA H,et al. Augmented renal clearance in critically ill patients:a systematic review[J].Clin Pharmacokinet,2018,57(9):1107-1121.
    [3] BAMGBOLA O.Review of vancomycin-induced renal toxicity:an update[J].Ther Adv Endocrinol Metab,2016,7(3):136-147.
    [4] 何娟,杨婉花.基于群体药动学的万古霉素个体化给药模式的建立和临床应用[J].中国临床药学杂志,2015,24(1):27-31.
    [5] 汤月秋,杨立川.心脏术后并发急性肾损伤的危险因素分析[J].实用医院临床杂志,2018,15(6):68-71.
    [6] 钟少榕,滕杰.心脏手术围术期血压管理与急性肾损伤[J].中华肾脏病杂志,2018,34(3):232-235.
    [7] 中国医药教育协会感染疾病专业委员会.抗菌药物药代动力学/药效学理论临床应用专家共识[J].中华结核和呼吸杂志, 2018,41(6):409-446.
    [8] EIDELSON A,MULDER B,KARCUTSKIE A,et al. 81augmented creatinine clearance in severely injured burn patients[J].J Burn Care Res,2018,39(suppl_1):S45-S46.
    [9] 陆灏迪,唐莲,薛盛敏,等.万古霉素群体药代动力学在肾功能亢进患者中的临床验证[J].中华危重病急救医学,2018,30(5):444-448.
    [10] 万古霉素临床应用剂量专家组.万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561-573.
    [11] BRUSSELAERS N,MONSTREY S,COLPAERT K,et al. Outcome of acute kidney injury in severe burns:a systematic review and meta-analysis[J].Intensive Care Med,2010,36(6):915-925.
    [12] HIDAYAT L K,HSU D I,QUIST R,et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections:efficacy and toxicity[J].Arch Intern Med,2006,166(19):2138-2144.
    [13] LIU C,BAYER A,COSGROVE S E,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children[J].Clin Infect Dis,2011,52(3):e18-e55.
    [14] SIME F B,UDY A A,ROBERTS J A.Augmented renal clearance in critically ill patients:etiology,definition and implications for beta-lactam dose optimization[J].Curr Opin Pharmacol,2015,24:1-6.
    [15] CHU Y,LUO Y F,QU L Y,et al. Application of vancomycin in patients with varying renal function,especially those with augmented renal clearance[J].Pharm Biol,2016,54(12):2802-2806.
    [16] 唐莲,陆灏迪,薛盛敏,等.肾功能亢进患者万古霉素的药代动力学及谷浓度影响因素研究[J].国际医药卫生导报,2018,24(5):621-628.
    [17] BAKKE V,SPORSEM H,VON DER LIPPEE,et al. Vancomycin levels are frequently subtherapeutic in critically ill patients:a prospective observational study[J].Acta Anaesthesiol Scand,2017,61(6):627-635.
    [18] UDY A A,PUTT M T,SHANMUGATHASAN S,et al. Augmented renal clearance in the Intensive Care Unit:an illustrative case series[J].Int J Antimicrob Agents,2010,35(6):606-608.
    [19] KAWANO Y,MORIMOTO S,IZUTANI Y,et al. Augmented renal clearance in Japanese intensive care unit patients:a prospective study[J].J Intensive Care,2016,4(1):62-68.
    [20] BARLETTA J F,MANGRAM A J,BYRNE M,et al. Identifying augmented renal clearance in trauma patients:validation of the augmented renal clearance in trauma intensive care scoring system[J].J Trauma Acute Care Surg,2017,82(4):665-671.
  • [1] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [2] 张莲卿, 骆岩, 杨提, 姚佳晨, 李文艳.  基于FAERS数据库的艾塞那肽微球不良事件信号挖掘与研究 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202403057
    [3] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
    [4] 李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华.  米格列醇激活UCP1介导棕色脂肪对冷暴露小鼠损伤的研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404005
    [5] 丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉.  消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
    [6] 邹思, 吴岩斌, 吴锦忠, 吴建国, 黄家兴.  虎奶菇菌核多糖功能化纳米硒抗疲劳功效研究 . 药学实践与服务, 2024, 42(10): 426-432. doi: 10.12206/j.issn.2097-2024.202206072
    [7] 唐淑慧, 凤美娟, 薛智霞, 鲁桂华.  帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
    [8] 宋红卫, 王燕, 方铭, 马云鹏, 钟超, 徐一新, 徐峰, 周婷.  2021−2023年我院药品不良反应的特点分析 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404041
    [9] 张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一.  药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
    [10] 崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺.  临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  4549
  • HTML全文浏览量:  509
  • PDF下载量:  325
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-12-19
  • 修回日期:  2019-03-22

肾功能亢进患者应用万古霉素致急性肾损伤的用药监护

doi: 10.3969/j.issn.1006-0111.2019.03.017
  • 1. 南京医科大学附属苏州医院药学部, 江苏 苏州 215002
  • 2. 上海交通大学医学院附属瑞金医院药学部, 上海 200025
    • 基金项目:  江苏省苏州市科技发展计划项目（SYSD2016152）；江苏省药学会医院药学基金项目（A201613）
  • 收稿日期: 2018-12-19
  • 修回日期: 2019-03-22

摘要: 目的 探讨肾功能亢进患者万古霉素个体化用药中出现急性肾损伤的原因。 方法 对南京医科大学附属苏州医院使用万古霉素且发生急性肾损伤的3个病例进行药学监护，分析使用群体药动学软件预测万古霉素谷浓度准确性差的原因，寻找发生万古霉素急性肾损伤的原因。 结果 在查明患者发生不良反应的原因后，对其进行针对性治疗，均获得较好的控制与转归。 结论 肾功能亢进患者出现万古霉素相关性肾损害主要为联用肾毒性药物、肾脏灌注不足，临床用药中需加强用药监护，提高万古霉素用药安全性。

English Abstract

陆灏迪, 唐莲, 方洁, 薛盛敏, 尚尔宁, 薛苏冬. 肾功能亢进患者应用万古霉素致急性肾损伤的用药监护[J]. 药学实践与服务, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
引用本文: 陆灏迪, 唐莲, 方洁, 薛盛敏, 尚尔宁, 薛苏冬. 肾功能亢进患者应用万古霉素致急性肾损伤的用药监护[J]. 药学实践与服务, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
shu
LU Haodi, TANG Lian, FANG Jie, XUE Shengmin, SHANG Erning, XUE Sudong. Drug monitoring of acute kidney injury induced by vancomycin in patients with augmented renal clearance[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
Citation: LU Haodi, TANG Lian, FANG Jie, XUE Shengmin, SHANG Erning, XUE Sudong. Drug monitoring of acute kidney injury induced by vancomycin in patients with augmented renal clearance[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(3): 274-278. doi: 10.3969/j.issn.1006-0111.2019.03.017
shu

    全文HTML

参考文献 (20)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计